BR9917006A - ácido niflúmico lipossÈmico - medicamentoantiinflamatório transdérmico - Google Patents

ácido niflúmico lipossÈmico - medicamentoantiinflamatório transdérmico

Info

Publication number
BR9917006A
BR9917006A BR9917006-0A BR9917006A BR9917006A BR 9917006 A BR9917006 A BR 9917006A BR 9917006 A BR9917006 A BR 9917006A BR 9917006 A BR9917006 A BR 9917006A
Authority
BR
Brazil
Prior art keywords
niflumic acid
liposomes
transdermal
liposomal
inflammatory drug
Prior art date
Application number
BR9917006-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Konstantinos Demetzos
Helen Kammenou
Michalis Rallis
Eorgios Papaioannou
Aristidis Georgopoulos
Georgiostsamouris
Ofia Hatziantoniou
Georgios Giannisis
Georgios Nounesis
Hristina Savva-Dimopoulou
Original Assignee
Gerolymatos P N Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerolymatos P N Sa filed Critical Gerolymatos P N Sa
Publication of BR9917006A publication Critical patent/BR9917006A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
BR9917006-0A 1998-12-24 1999-12-22 ácido niflúmico lipossÈmico - medicamentoantiinflamatório transdérmico BR9917006A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR98100469 1998-12-24
PCT/GR1999/000048 WO2000038681A1 (en) 1998-12-24 1999-12-22 Liposomic niflumic acid - new transdermal anti-inflammatory medicine

Publications (1)

Publication Number Publication Date
BR9917006A true BR9917006A (pt) 2001-10-30

Family

ID=10943556

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9917006-0A BR9917006A (pt) 1998-12-24 1999-12-22 ácido niflúmico lipossÈmico - medicamentoantiinflamatório transdérmico

Country Status (17)

Country Link
EP (1) EP1140089A1 (is)
JP (1) JP2002533394A (is)
KR (1) KR20010089889A (is)
CN (1) CN1331592A (is)
AU (1) AU1673400A (is)
BR (1) BR9917006A (is)
CA (1) CA2357765A1 (is)
CZ (1) CZ20012240A3 (is)
GR (1) GR1003359B (is)
HU (1) HUP0104853A3 (is)
IL (1) IL143499A0 (is)
IS (1) IS5964A (is)
MX (1) MXPA01006462A (is)
NO (1) NO20013015L (is)
PL (1) PL349344A1 (is)
SK (1) SK7962001A3 (is)
WO (1) WO2000038681A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1599183A2 (en) * 2002-11-26 2005-11-30 Gilead Sciences, Inc. Method of drug loading in liposomes by gradient
KR20060015534A (ko) 2003-04-25 2006-02-17 더 펜 스테이트 리서치 파운데이션 성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
JP4791082B2 (ja) * 2005-05-30 2011-10-12 株式会社クラレ リポソームおよびそれを含む皮膚外用剤
JP4931369B2 (ja) * 2005-05-31 2012-05-16 ポーラ化成工業株式会社 リポソームおよびそれを含む処置用の組成物
JP5846711B2 (ja) 2005-06-09 2016-01-20 メダ アーベー 炎症性疾患の治療のための方法及び組成物
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
WO2012016048A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti- viral azide-containing compounds
AU2013212068B2 (en) 2012-01-26 2018-02-15 Life Technologies Corporation Methods for increasing the infectivity of viruses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
AU587299B2 (en) * 1985-11-27 1989-08-10 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti- inflammatory drug
EP0249561B1 (en) * 1986-06-12 1992-05-13 The Liposome Company, Inc. Compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
WO1996032930A1 (en) * 1995-04-18 1996-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition

Also Published As

Publication number Publication date
CN1331592A (zh) 2002-01-16
IS5964A (is) 2001-06-08
MXPA01006462A (es) 2002-06-04
CA2357765A1 (en) 2000-07-06
CZ20012240A3 (cs) 2001-11-14
HUP0104853A3 (en) 2003-05-28
SK7962001A3 (en) 2002-02-05
WO2000038681A1 (en) 2000-07-06
GR1003359B (el) 2000-04-10
IL143499A0 (en) 2002-04-21
PL349344A1 (en) 2002-07-15
JP2002533394A (ja) 2002-10-08
EP1140089A1 (en) 2001-10-10
HUP0104853A2 (hu) 2002-05-29
NO20013015D0 (no) 2001-06-18
AU1673400A (en) 2000-07-31
NO20013015L (no) 2001-06-18
KR20010089889A (ko) 2001-10-12

Similar Documents

Publication Publication Date Title
AU783758B2 (en) Use of creatine or creatine compounds for skin preservation
CA1146070A (en) Topical triethylenetetramine-containing pharmaceutical compositions and methods of use
US6228891B1 (en) Use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
EP0229654B1 (en) Treatment of non-acne inflammatory and infectious dermatoses
JP2005526822A5 (is)
IE58101B1 (en) Topical composition
KR20060128969A (ko) 피부 염증 반응을 치료하는 조성물 및 그 제조방법
BR9917006A (pt) ácido niflúmico lipossÈmico - medicamentoantiinflamatório transdérmico
JPH04501122A (ja) ▲ざ▼瘡又は乾癬に関する皮膚の治療のための化合物及び方法
PT723778E (pt) Composicao indutora de apoptose compreendendo um factor que aumenta a taxa intracelular de metional ou de malondialdeido
KR950000142A (ko) 피부질환치료용 약제조성물 제조에 사용되는 히드록시산함유 l-카르니틴에스테르 및 아실 l-카르니틴에스테르의 용도
WO1999027924A3 (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
US20040265345A1 (en) Treatment of skin damage using acetyl carnitine and lipoic acid
Shek et al. Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery
EP1152748A1 (en) Method and composition for treating acne
AU754420B2 (en) Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases
BR0117197A (pt) Formulação de medicamento contendo ciclosporina aplicação do mesmo
Farshi et al. In-vivo studies in the treatment of oral ulcers with liposomal dexamethasone sodium phosphate
KR950031084A (ko) 국소용 진양(鎭洋) 조성물
BR0010459A (pt) Preparação de lipossoma contendo derivado de ácido pipecólico e preparação sólida
WO2007073727A1 (de) Neue kompositionen gegen alkyl-acyl-gpc, seine derivate und produkte
EP1360958B1 (en) Liposomic formulation of clobetasol propionate
IE890896L (en) Topically applied gold organic complex
EP3145490B1 (en) Liposomes containing di-homo-gamma linolenic acid (dgla), formulations containing them and use thereof
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]